International journal of surgery (London, England)
Clarifying the survival impact of immunotherapy in HR+/HER2- metastatic breast cancer: methodological caveats from a real-world perspective--letter to the editor.
Man Sun, Dan Zang, Jun Chen
Published: 202510.1097/JS9.0000000000003758
No abstract available for this study.